Patents Assigned to SignalChem Lifesciences Corp.
  • Quinazoline derivatives as TAM family kinase inhibitors
    Patent number: 9771333
    Abstract: Disclosed are compounds, compositions and methods for treating diseases, syndromes, conditions and disorders that are affected by the modulation of the activity of, e.g., the inhibition of, one or more members of the TAM family kinases.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: September 26, 2017
    Assignee: SignalChem Lifesciences Corp.
    Inventor: Zaihui Zhang